Fiduciary Alliance’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Sell
7,309
-329
-4% -$26.5K 0.04% 343
2026
Q1
$665K Buy
7,638
+223
+3% +$21.4K 0.04% 326
2025
Q4
$712K Sell
7,415
-240
-3% -$23.3K 0.05% 289
2025
Q3
$729K Sell
7,655
-466
-6% -$42.8K 0.05% 277
2025
Q2
$708K Buy
8,121
+2,068
+34% +$175K 0.05% 272
2025
Q1
$544K Buy
6,053
+169
+3% +$15.1K 0.05% 241
2024
Q4
$470K Buy
+5,884
New +$509K 0.05% 244
2023
Q3
Sell
-394
Closed -$34.7K 627
2023
Q2
$34.7K Buy
+394
New +$33.9K 0.01% 360
2023
Q1
Sell
-177
Closed -$13.8K 560
2022
Q4
$13.8K Buy
+177
New +$14.3K ﹤0.01% 354

Other funds holding MDT

Fiduciary Alliance's MDT Position: Q2 2026 in Review

Fiduciary Alliance reduced its Medtronic (MDT) stake by 4.3% in Q2 2026, selling an estimated $26.5K and leaving 7,309 shares worth $572K. The position accounts for 0.04% of the portfolio, ranked #343.

Fiduciary Alliance first reported a position in MDT in Q4 2022 and has held it in 9 quarters since. The position peaked at $729K in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fiduciary Alliance held 7,309 shares of Medtronic worth $572K as of Q2 2026.
  • Fiduciary Alliance sold 329 Medtronic shares in Q2 2026, an estimated $26.5K.
  • Medtronic made up 0.04% of Fiduciary Alliance's portfolio in Q2 2026, its #343 holding.
  • Fiduciary Alliance first reported a position in Medtronic in Q4 2022 and has held it in 9 quarters since.
  • Fiduciary Alliance's Medtronic position peaked at $729K in Q3 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.